Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $209B
1-Year Est. Return 39.39%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+39.39%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$223B
AUM Growth
+$4.26B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,496
New
Increased
Reduced
Closed

Top Buys

1 +$574M
2 +$573M
3 +$446M
4
MU icon
Micron Technology
MU
+$389M
5
CP icon
Canadian Pacific Kansas City
CP
+$387M

Top Sells

1 +$1.19B
2 +$1.11B
3 +$557M
4
ADSK icon
Autodesk
ADSK
+$554M
5
RNAM
Avidity Biosciences
RNAM
+$490M

Sector Composition

1 Technology 34.83%
2 Healthcare 19.29%
3 Consumer Discretionary 9.89%
4 Financials 9.74%
5 Industrials 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NYT icon
451
New York Times
NYT
$12.2B
$40.5M 0.02%
584,073
+151,526
HR icon
452
Healthcare Realty
HR
$6.8B
$40.4M 0.02%
2,380,380
-761,233
CPRX icon
453
Catalyst Pharmaceutical
CPRX
$3.83B
$40.1M 0.02%
1,719,767
+1,147,565
DMRA
454
Damora Therapeutics
DMRA
$1.41B
$40M 0.02%
+1,739
DCI icon
455
Donaldson
DCI
$9.92B
$39.9M 0.02%
450,349
-488,812
HIW icon
456
Highwoods Properties
HIW
$2.96B
$39.8M 0.02%
1,540,888
+275,858
AVDL
457
DELISTED
Avadel Pharmaceuticals
AVDL
$39.3M 0.02%
1,823,865
-5,605,853
BNTC icon
458
Benitec Biopharma
BNTC
$363M
$39.3M 0.02%
2,911,688
JXN icon
459
Jackson Financial
JXN
$7.43B
$39.3M 0.02%
368,277
+98,805
FBRX icon
460
Forte Biosciences
FBRX
$372M
$39.2M 0.02%
1,425,785
+21,943
QRVO icon
461
Qorvo
QRVO
$9.04B
$38.9M 0.02%
460,789
+194,731
CAMP icon
462
CAMP4 Therapeutics
CAMP
$207M
$38.8M 0.02%
6,307,636
+1,666,666
VMI icon
463
Valmont Industries
VMI
$10.6B
$38.4M 0.02%
95,471
+38,557
HOLX
464
DELISTED
Hologic
HOLX
$38.1M 0.02%
511,314
-94,765
NEE icon
465
NextEra Energy
NEE
$179B
$37.9M 0.02%
471,666
+379,796
WFC icon
466
Wells Fargo
WFC
$243B
$37.1M 0.02%
397,645
+2,882
ENTG icon
467
Entegris
ENTG
$21.8B
$37M 0.02%
438,716
-14,720
LMRI
468
Lumexa Imaging Holdings
LMRI
$722M
$36.9M 0.02%
+1,992,453
DRVN icon
469
Driven Brands
DRVN
$2.19B
$36.7M 0.02%
2,477,179
+209,883
GLPI icon
470
Gaming and Leisure Properties
GLPI
$13.1B
$36.6M 0.02%
818,191
+6,100
CMS icon
471
CMS Energy
CMS
$22.2B
$36.5M 0.02%
522,492
-6,927
BLBD icon
472
Blue Bird Corp
BLBD
$2.29B
$36.5M 0.02%
777,625
+84,488
ALSN icon
473
Allison Transmission
ALSN
$9.63B
$36.2M 0.02%
369,976
+113,108
CAH icon
474
Cardinal Health
CAH
$45.6B
$36.2M 0.02%
176,017
-1,920
PPL icon
475
PPL Corp
PPL
$26.2B
$36M 0.02%
1,028,626
+289,581